Barbieri MA - Search Results

1

Dupilumab in chronic rhinosinusitis with nasal polyps: Real life data in a multicentric Sicilian experience.

Galletti C, Ragusa M, Sireci F, Ciodaro F, Barbieri MA, Giunta G, Grigaliute E, Immordino A, Lorusso F, Dispenza F, Freni F, Galletti F, Gallina S, La Mantia I, Galletti B. Galletti C, et al. Among authors: barbieri ma. Am J Otolaryngol. 2024 Jan-Feb;45(1):104106. doi: 10.1016/j.amjoto.2023.104106. Epub 2023 Nov 5. Am J Otolaryngol. 2024. PMID: 37948824 Free article.

2

Effectiveness and safety profile of mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a tertiary care.

Galletti C, Ciodaro F, Barbieri MA, Gambino F, Ferrisi MG, Portelli D, Catalano N, Spina E, Freni F, Galletti B. Galletti C, et al. Among authors: barbieri ma. Am J Otolaryngol. 2024 Apr 21;45(4):104329. doi: 10.1016/j.amjoto.2024.104329. Online ahead of print. Am J Otolaryngol. 2024. PMID: 38696895

3

Neuropsychiatric adverse drug reactions with oral tyrosine kinase inhibitors in metastatic colorectal cancer: an analysis from the FDA Adverse Event Reporting System.

Barbieri MA, Russo G, Sorbara EE, Cicala G, Franchina T, Santarpia M, Speranza D, Spina E, Silvestris N. Barbieri MA, et al. Front Oncol. 2023 Oct 31;13:1268672. doi: 10.3389/fonc.2023.1268672. eCollection 2023. Front Oncol. 2023. PMID: 38023143 Free PMC article.

4

Timing Matters: A Machine Learning Method for the Prioritization of Drug-Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure.

Battini V, Cocco M, Barbieri MA, Powell G, Carnovale C, Clementi E, Bate A, Sessa M. Battini V, et al. Among authors: barbieri ma. Drug Saf. 2024 Apr 30. doi: 10.1007/s40264-024-01430-8. Online ahead of print. Drug Saf. 2024. PMID: 38687463

5

Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review.

Cocco M, Carnovale C, Clementi E, Barbieri MA, Battini V, Sessa M. Cocco M, et al. Among authors: barbieri ma. Expert Rev Clin Pharmacol. 2024 Apr 18:1-13. doi: 10.1080/17512433.2024.2343875. Online ahead of print. Expert Rev Clin Pharmacol. 2024. PMID: 38619027 Review.

6

Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data.

Cicala G, Barbieri MA, Russo G, Salvo F, Spina E. Cicala G, et al. Among authors: barbieri ma. Pharmaceuticals (Basel). 2024 Mar 6;17(3):342. doi: 10.3390/ph17030342. Pharmaceuticals (Basel). 2024. PMID: 38543128 Free PMC article.

7

Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues.

Battini V, Barbieri MA, Carnovale C, Spina E, Clementi E, Sessa M. Battini V, et al. Among authors: barbieri ma. J Neurol. 2024 Mar 22. doi: 10.1007/s00415-024-12300-9. Online ahead of print. J Neurol. 2024. PMID: 38517522

8

Drug Repurposing in Crohn's Disease Using Danish Real-World Data.

Shakibfar S, Allin KH, Jess T, Barbieri MA, Battini V, Simoncic E, Kirchgesner J, Ulven T, Sessa M. Shakibfar S, et al. Among authors: barbieri ma. Pragmat Obs Res. 2024 Feb 21;15:17-29. doi: 10.2147/POR.S444569. eCollection 2024. Pragmat Obs Res. 2024. PMID: 38404739 Free PMC article.

9

Cardiovascular Adverse Drug Reactions of Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies for Migraine Prevention: An Analysis from the European Spontaneous Adverse Event Reporting System.

Sorbara EE, Barbieri MA, Russo G, Cicala G, Spina E. Sorbara EE, et al. Among authors: barbieri ma. BioDrugs. 2024 Mar;38(2):275-285. doi: 10.1007/s40259-024-00651-8. Epub 2024 Feb 25. BioDrugs. 2024. PMID: 38402495

10

Community-Engaged Research: COVID-19 Testing, Infection, and Vaccination among Underserved Minority Communities in Miami, Florida.

Martin HR, Brown DR, Fluney E, Trepka MJ, Marty AM, Roldan EO, Liu Q, Barbieri MA, Baum MK. Martin HR, et al. Among authors: barbieri ma. Vaccines (Basel). 2024 Jan 24;12(2):117. doi: 10.3390/vaccines12020117. Vaccines (Basel). 2024. PMID: 38400101 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

354 results

Search Page